{"nctId":"NCT02595073","briefTitle":"Clinical Study to Evaluate the Efficacy and Safety of Desoximetasone (DSXS) With Atopic Dermatitis","startDateStruct":{"date":"2015-09-04","type":"ACTUAL"},"conditions":["Atopic Dermatitis"],"count":124,"armGroups":[{"label":"DSXS topical product","type":"EXPERIMENTAL","interventionNames":["Drug: DSXS"]},{"label":"Placebo topical product","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"DSXS","otherNames":["Active"]},{"name":"Placebo","otherNames":["vehicle"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n\\- male and non-pregnant females, age 6 months or older, with a confirmed diagnosis of moderate to severe atopic dermatitis (AD)\n\nExclusion Criteria:\n\n\\- Lacks stable diagnosis of atopic dermatitis or has been diagnosed with mild atopic dermatitis.","healthyVolunteers":false,"sex":"ALL","minimumAge":"6 Months","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"The Number of Patients in Each Treatment Group That Have Clinical Success","description":"Clinical Success defined using the following scores at Visit 4 (Day 28 ± 2): At least a 2-grade improvement from the baseline IGA score (i.e., clear \\[0\\] or almost clear \\[1\\]) AND A score of clear or mild (0 or 1) for both erythema and induration/papulation/edema","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"21","spread":null},{"groupId":"OG001","value":"27","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in %BSA Affected at Day 28 ± 2","description":"The change in %BSA Affected from Visit 1 Baseline (Day 1) to Visit 4 End of Treatment (Day 28 ± 2)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-13.81","spread":"0.99"},{"groupId":"OG001","value":"-13.24","spread":"0.96"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":61},"commonTop":["Nasopharyngitis","Headache","Diarrhoea","Application site pain","Oral herpes"]}}}